InvestorsHub Logo
Followers 167
Posts 35887
Boards Moderated 4
Alias Born 10/20/2019

Re: jedijazz post# 2759

Tuesday, 08/22/2023 12:33:14 PM

Tuesday, August 22, 2023 12:33:14 PM

Post# of 2791
$NBIO announced today that the Company has been cleared by the FDA to begin Phase II clinical trials for brain cancer. This milestone allows the Company to continue advancing Pritumumab through the regulatory clinical processes in its use against Brain Tumors including Glioblastoma
https://finance.yahoo.com/news/nascent-biotech-begin-phase-ii-120000548.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NBIO News